SCOPUS 정보 검색 플랫폼

Volumn 31, Issue 6, 2013, Pages 1626-1627

Sorafenib in patients with progressive malignant solitary fibrous tumors: A subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)

(7) Valentin, T a Fournier, C b Penel, N b Bompas, E c Chaigneau, L d Isambert, N e Chevreau, C a

a INSTITUT CLAUDIUS REGAUD (France)

b CENTRE OSCAR LAMBRET (France)

c Centre Catherine de Sienne (France)

d UNIVERSITY HOSPITAL JEAN MINJOZ (France)

e Medical Oncology (France)

Author keywords

Antiangiogenic treatment; Soft tissue sarcoma; Solitary fibrous tumor; Sorafenib

Indexed keywords

SORAFENIB;

ADULT; AGED; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAND FOOT SYNDROME; HUMAN; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE CANCER; SOLITARY FIBROUS TUMOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NIACINAMIDE; PHENYLUREA COMPOUNDS; PROTEIN KINASE INHIBITORS; SOLITARY FIBROUS TUMORS; TREATMENT OUTCOME;

EID: 84888628569 PISSN: 01676997 EISSN: 15730646 Source Type: Journal
DOI: 10.1007/s10637-013-0023-z Document Type: Article

Times cited : (48)

References (6)

1
- 84861091023
- Solitary fibrous tumors and so-called hemangiopericytoma
- 10.1155/2012/690251 22566753 10.1155/2012/690251
- Penel N, Amela EY, Decanter G, Robin YM, Marec-Berard P (2012) Solitary fibrous tumors and so-called hemangiopericytoma. Sarcoma 2012:690251. doi: 10.1155/2012/690251
- (2012) Sarcoma , vol.2012 , pp. 690251
- Penel, N.¹ Amela, E.Y.² Decanter, G.³ Robin, Y.M.⁴ Marec-Berard, P.⁵

2
- 84888629125
- The role of chemotherapy in advanced solitary fibrous tumors: A retrospective analysis
- 10.1186/2045-3329-3-7 23663788 10.1186/2045-3329-3-7 1:CAS:528: DC%2BC3sXptFanurg%3D
- Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM (2013) The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res 3(1):7. doi: 10.1186/2045-3329-3-7
- (2013) Clin Sarcoma Res , vol.3 , Issue.1 , pp. 7
- Park, M.S.¹ Ravi, V.² Conley, A.³ Patel, S.R.⁴ Trent, J.C.⁵ Lev, D.C.⁶ Lazar, A.J.⁷ Wang, W.L.⁸ Benjamin, R.S.⁹ Araujo, D.M.¹⁰

3
- 84869792128
- Sunitinib malate in solitary fibrous tumor (SFT)
- 10.1093/annonc/mds143 22711763 10.1093/annonc/mds143 1:STN:280: DC%2BC38jivFOrsg%3D%3D
- Stacchiotti S, Negri T, Libertini M, Palassini E, Marrari A, De Troia B, Gronchi A, Dei Tos AP, Morosi C, Messina A, Pilotti S, Casali PG (2012) Sunitinib malate in solitary fibrous tumor (SFT). Ann Oncol 23(12):3171-3179. doi: 10.1093/annonc/mds143
- (2012) Ann Oncol , vol.23 , Issue.12 , pp. 3171-3179
- Stacchiotti, S.¹ Negri, T.² Libertini, M.³ Palassini, E.⁴ Marrari, A.⁵ De Troia, B.⁶ Gronchi, A.⁷ Dei Tos, A.P.⁸ Morosi, C.⁹ Messina, A.¹⁰ Pilotti, S.¹¹ Casali, P.G.¹²

4
- 79961219491
- Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
- 10.1002/cncr.26098 21480200 10.1002/cncr.26098 1:CAS:528: DC%2BC3MXhtlaqu7zM
- Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM (2011) Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 117(21):4939-4947. doi: 10.1002/cncr.26098
- (2011) Cancer , vol.117 , Issue.21 , pp. 4939-4947
- Park, M.S.¹ Patel, S.R.² Ludwig, J.A.³ Trent, J.C.⁴ Conrad, C.A.⁵ Lazar, A.J.⁶ Wang, W.L.⁷ Boonsirikamchai, P.⁸ Choi, H.⁹ Wang, X.¹⁰ Benjamin, R.S.¹¹ Araujo, D.M.¹²

5
- 84856233838
- Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas
- 10.1002/cncr26334 10.1002/cncr.26334
- von Mehren M, Rankin C, Goldblum JR, Demetri GD, Bramwell V, Ryan CW, Borden E (2012) Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas. Cancer 118(3):770-776. doi: 10.1002/cncr26334
- (2012) Cancer , vol.118 , Issue.3 , pp. 770-776
- Von Mehren, M.¹ Rankin, C.² Goldblum, J.R.³ Demetri, G.D.⁴ Bramwell, V.⁵ Ryan, C.W.⁶ Borden, E.⁷

6
- 67650312341
- Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas
- 10.1200/JCO.2008.20.9890 19451429 10.1200/JCO.2008.20.9890 1:CAS:528:DC%2BD1MXhtFWitb3E
- George S, Merriam P, Maki RG, Van den Abbeele AD, Yap JT, Akhurst T, Harmon DC, Bhuchar G, O'Mara MM, D'Adamo DR, Morgan J, Schwartz GK, Wagner AJ, Butrynski JE, Demetri JD, Keohan ML (2009) Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. J Clin Oncol 27(19):3154-3160. doi: 10.1200/JCO.2008.20.9890
- (2009) J Clin Oncol , vol.27 , Issue.19 , pp. 3154-3160
- George, S.¹ Merriam, P.² Maki, R.G.³ Van Den Abbeele, A.D.⁴ Yap, J.T.⁵ Akhurst, T.⁶ Harmon, D.C.⁷ Bhuchar, G.⁸ O'Mara, M.M.⁹ D'Adamo, D.R.¹⁰ Morgan, J.¹¹ Schwartz, G.K.¹² Wagner, A.J.¹³ Butrynski, J.E.¹⁴ Demetri, J.D.¹⁵ Keohan, M.L.¹⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.